Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain
about
Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 familyMembrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cellsUnfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacyEquilibrative nucleoside transporters-A review.Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake.Boron-Doped Diamond Microelectrodes Reveal Reduced Serotonin Uptake Rates in Lymphocytes from Adult Rhesus Monkeys Carrying the Short Allele of the 5-HTTLPR.Organic cation transporter inhibition increases medial hypothalamic serotonin under basal conditions and during mild restraintAdenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cationsSelective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3Tyrosine 112 is essential for organic cation transport by the plasma membrane monoamine transporterDopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.Expression and immunolocalization of the plasma membrane monoamine transporter in the brainRepeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gunAutism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene.Molecular analysis and structure-activity relationship modeling of the substrate/inhibitor interaction site of plasma membrane monoamine transporter.The physiological role of drug transporters.Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter.Residue Ile89 in human plasma membrane monoamine transporter influences its organic cation transport activity and sensitivity to inhibition by dilazepAn immunohistochemical analysis of SERT in the blood-brain barrier of the male rat brainPotent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease InhibitorsMetformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine.Enhanced activity of human serotonin transporter variants associated with autism.Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3).Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics.The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition.The promiscuity of the dopamine transporter: implications for the kinetic analysis of [3H]serotonin uptake in rat hippocampal and striatal synaptosomes.Selective serotonin reuptake inhibitors pathwayDifferential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine
P2860
Q24655176-5A24661F-AF9C-4EBD-8BB0-B7C31BE3079BQ24655213-7A9FD2A4-94B2-4294-8577-E916D6EF5B59Q24658095-E0188801-0104-4D9A-B155-D57660D69CA2Q30244329-AEB3DFAA-02A7-4D92-A205-E996F6283F85Q33584577-136533D4-3AB0-48D4-A81A-112547CED8CBQ33747022-05425688-6107-4E29-8B92-20B9B83F5462Q33780097-61835C4D-94E4-48E5-B2FB-6C8BB67D1BC7Q34211096-41D1B4CD-0868-4C32-8F44-95DC7FC02422Q34359911-D23CC8A0-121D-43D3-AFDC-BFDE8D834098Q34367791-32EE4516-CED5-4418-8E39-D32BBE51BF4BQ34540567-C26A0031-D382-42E1-89A5-71EA0FC18699Q34615851-32319AD0-9018-4FDA-BCFF-AFCE9B155FDEQ34721872-7E15A481-6007-49A2-BBB7-9F1B3E29B46CQ35208018-95930B4A-D1E5-4C87-B80B-F1A2DF9E2934Q35429797-DFA53F15-8A20-45EB-B241-BC737F783DDFQ35563701-53C627F1-59FE-40CD-A8FD-9A2622AEF108Q35996455-73E0A2D4-E0BA-45FD-9279-6ECEA92A2861Q36024314-E5728A7F-86EB-4BDD-87FF-798086F86E71Q36075219-EFD08528-278D-44FE-A827-69AD019B4E70Q36186145-02DEBE99-4AFD-4614-8E5B-D52DF41FDC99Q37168725-B5F12931-26A1-406D-83FC-C52603723740Q37171521-3BD93002-1C6E-437B-873B-305D2C419E09Q37371545-9D64C71D-1902-4E4A-A9C6-3BD785660B41Q38851414-025B1590-A17F-4812-A123-DCA209D177C2Q38923212-41DB69DD-D7B0-4FF6-A462-C3D4F2F3DB68Q41884930-69057BBD-7AF2-4DAC-9676-9945115CD545Q42017738-46C362E3-C04F-47FF-8CBD-824AEA68CC30Q58750811-9A6F3817-AD56-4586-BFA6-5F63F5D0CDDD
P2860
Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Evidence for significant contr ...... onin uptake in the human brain
@ast
Evidence for significant contr ...... onin uptake in the human brain
@en
Evidence for significant contr ...... onin uptake in the human brain
@nl
type
label
Evidence for significant contr ...... onin uptake in the human brain
@ast
Evidence for significant contr ...... onin uptake in the human brain
@en
Evidence for significant contr ...... onin uptake in the human brain
@nl
prefLabel
Evidence for significant contr ...... onin uptake in the human brain
@ast
Evidence for significant contr ...... onin uptake in the human brain
@en
Evidence for significant contr ...... onin uptake in the human brain
@nl
P2093
P2860
P1476
Evidence for significant contr ...... onin uptake in the human brain
@en
P2093
Joanne Wang
Karen Engel
Mingyan Zhou
P2860
P304
P356
10.1016/J.BCP.2006.09.008
P407
P577
2007-01-01T00:00:00Z